Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma.

The Journal of clinical investigation·2026
Same author

THE ORIGINS AND PROGRESSION OF PYLORIC METAPLASIA FOLLOWING GASTRIC MUCOSAL INJURY.

Physiological reviews·2026
Same author

Correction: A novel long noncoding RNA‑LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.

Journal of cancer research and clinical oncology·2026
Same author

Stress-Responsive Protein IFRD1 Protects Assembled Ribosomes via a Ribosome-Salvaging Mechanism.

bioRxiv : the preprint server for biology·2026
Same author

Regulation of STK38 by autophagy governs YAP1 activity during paligenosis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Development and external validation of a machine learning model for predicting in-hospital mortality in ICU patients with diabetic kidney disease: a study utilizing the MIMIC database and a Chinese cohort.

Frontiers in endocrinology·2026
Same journal

Focus on MAIT cell antigens fueling biliary liver injury.

Cellular and molecular gastroenterology and hepatology·2026
Same journal

Intervening in PIDD1 to Decrease Treg Cell Recruitment Boosts the Effectiveness of Radiofrequency Ablation Combined with anti-PD-1 Therapy in HCC.

Cellular and molecular gastroenterology and hepatology·2026
Same journal

Hepatocyte TGF-β-ORP3 signaling axis promotes hepatic stellate cell activation and liver fibrogenesis in mice.

Cellular and molecular gastroenterology and hepatology·2026
Same journal

Elevated TREM2 Expression in Tumor-associated Macrophages Suppresses Cytotoxic T Cell Infiltration and Facilitates Immune Escape in Colorectal Cancer.

Cellular and molecular gastroenterology and hepatology·2026
Same journal

Dietary Protein Source Mediates Colitis Pathogenesis Through Bacterial Modulation of Bile Acids.

Cellular and molecular gastroenterology and hepatology·2026
Same journal

Conducting the Orchestra: Non-Parenchymal Cells Direct Hepatocyte Functions in Steatotic Liver Disease.

Cellular and molecular gastroenterology and hepatology·2026
See all related articles

Related Experiment Video

Updated: Oct 19, 2025

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach
08:45

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach

Published on: January 26, 2024

1.7K

Gastric Organoids: Progress and Remaining Challenges.

Min-Jiao Pang1, Joseph R Burclaff2, Ramon Jin3

  • 1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Urumqi, China.

Cellular and Molecular Gastroenterology and Hepatology
|September 21, 2021
PubMed
Summary
This summary is machine-generated.

Gastric organoids derived from human or mouse tissues offer promising models for studying stomach diseases and testing new drugs. These advanced models could lead to personalized treatments for gastric cancer.

Keywords:
Gastric CancerOrganoidsPreclinical TrialStomachTumor Microenvironment

More Related Videos

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

35.7K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

597

Related Experiment Videos

Last Updated: Oct 19, 2025

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach
08:45

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach

Published on: January 26, 2024

1.7K
Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

35.7K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

597

Area of Science:

  • Gastroenterology and Regenerative Medicine
  • Cancer Biology and Therapeutics

Background:

  • Significant physiological differences between mouse and human stomachs limit the translational value of mouse models for gastric research and drug development.
  • Gastric cancer (GC) presents a global health challenge due to its high mortality and the limitations of current treatment strategies, exacerbated by the disease's heterogeneity.

Purpose of the Study:

  • To review the advancements in gastric organoid technology, focusing on models derived from human and mouse tissues.
  • To explore the potential of gastric organoids in preclinical drug screening and precision medicine for gastric cancer.

Main Methods:

  • Discussion of various methods for culturing gastric organoids from adult tissues and pluripotent stem cells.
  • Analysis of studies utilizing both human and mouse gastric organoid models.

Main Results:

  • Gastric organoids provide a more physiologically relevant model compared to traditional methods.
  • Organoid systems show significant promise for high-throughput preclinical drug screening and personalized medicine approaches.

Conclusions:

  • Gastric organoids represent a rapidly evolving field with the potential to overcome limitations of current models.
  • These models are expected to significantly advance the development of novel therapeutic strategies for gastric cancer patients.